Cost-effectiveness model of use of genetic testing as an aid in assessing the likely benefit of aspirin therapy for primary prevention of cardiovascular disease (Q43813573)
Jump to navigation
Jump to search
scientific article published on 5 May 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness model of use of genetic testing as an aid in assessing the likely benefit of aspirin therapy for primary prevention of cardiovascular disease |
scientific article published on 5 May 2012 |
Statements
1 reference
Cost-effectiveness model of use of genetic testing as an aid in assessing the likely benefit of aspirin therapy for primary prevention of cardiovascular disease (English)
1 reference
Dov Shiffman
1 reference
Katherine Slawsky
1 reference
Lauren Fusfeld
1 reference
James J Devlin
1 reference
Thomas F Goss
1 reference
5 May 2012
1 reference
1 reference
Identifiers
1 reference